Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

HIGHLIGHTS

• who: H. C. Donker from the DepartmentUniversity of, .001, RB Groningen, The Netherlands. have published the article: Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer, in the Journal: Scientific Reports Scientific Reports
• what: Next, the authors aimed to explain the predictiveness of SBS4 and SBS87 attributed mutations by looking for differences at the RNA level. Since the copy number variants span large portions of the genome (both exonic and intronic regions), the authors report the total, whole genome, copy number attributions.
• how: For the discovery cohort (Miao . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.